Files
Download Full Text (638 KB)
Contents
- Protecting the Patient during Radiation Theraphy: Staff expertise and equipment accuracy are essential to safe and effective treatment
- Compass Fall 2010: Stage II Colon Cancer: Adjuvant Therapy? After Surgery, some patients benefit from chemotherapy
- HOUSE CALL: Managing Cancer-Related Pain
- INBRIEF: Researchers identify Enzyme Involved in Chemotherapy Resistance
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
10-1-2010
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Buchholz, Thomas A.; Ibbott, Geoffrey S.; Hayden, Sandra; Kopetz, Scott; Eng, Cathy; Overman, Michael J.; Chen, Junjie; DNA Damage; FAN1 protein, human; Multifunctional Enzymes; Platinum Compounds; FANCI protein, human; Fanconi Anemia Complementation Group Proteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Genes, BRCA1; Genes, BRCA2; Cancer Pain; Colonic Neoplasms; Neoplasm Staging; Chemotherapy, Adjuvant; Fluorouracil; Colorectal Surgery; Microsatellite Repeats; Microsatellite Instability; Clinical Trials as Topic; Radiotherapy; Radiotherapy, Computer-Assisted; Radiotherapy Planning, Computer-Assisted; Patient Safety.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Hoseman, Sunni and Deming, Stephanie, "OncoLog Volume 55, Number 10, October 2010" (2010). OncoLog MD Anderson's Report to Physicians (All issues). 209.
https://openworks.mdanderson.org/oncolog/209
Conditions Governing Access
Open
